HighLife SAS
http://www.highlifemedical.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From HighLife SAS
Digital Health Roundup: What’s Hot On Investment; Diabetes; AI
In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb looks back at ADA 2023 highlights and her interviews with diabetes company execs. Reed Miller discusses his Cardio Conversation with Volta Medical and Hannah Daniel discusses the FDA’s Clinical Decision Support Software final guidance.
Investor Eye: Sofinnova Partners Are Redefining And Disobeying The Venture Investment Commandments
Sofinnova Partners has played an important role in defining the medtech investment space for the past 50 years, helping bring to market a plethora of life-saving technologies, even when they appear, initially, to be risky.
Edwards Undeterred By Latest Speed Bump In Transcatheter Mitral Valve Program
Edwards has temporarily paused the FORTIS clinical program evaluating a new transcatheter mitral valve to resolve valve thrombosis issues that emerged in the first 20 patients.
US Heart Valve Treatments Market Fueled By New Transcatheter Valves
The US heart valve treatments market will reach $1.7 billion by 2019, driven by advances in percutaneous heart valve repair and replacement products and a growing number of competitors entering this space. With US sales of transcatheter aortic valve replacement systems set to almost triple in the next several years, the combined US market for products to treat heart valve disorders is expected to grow at a CAGR of 7.7%.
Company Information
- Industry
-
Medical Devices
- Infusion Therapy Equipment and Supplies
- Other Names / Subsidiaries
-
- HighLife Medica
- HighLife S.A.S.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice